Osiris Therapeutics, Inc. To Present At The Canaccord Genuity Medical Technology And Diagnostics Forum

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity Medical Technology and Diagnostics Forum on Thursday, November 19, 2015 at 2:30 p.m. ET at the Westin Grand Central Hotel, in New York, NY.

Help employers find you! Check out all the jobs and post your resume.